Form D · Biotechnology

EFFICAS INC

Boulder, CO · CIK 0001278549

Offering snapshot reported Oct 22, 2009 · SEC filing

Reported sold
$500K
Offering amount: $1M
Investors reported
3
Form D · investor count
Minimum accepted
$145K
Reported outside-investor minimum
First sale
Mar 10, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$250K$500KMar 24, 2009: $200,000.00Mar 24, 2009Oct 22, 2009: $500,000.00Oct 22, 2009

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$200,000 → $500,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 22, 2009Amendment$500,000$300,000vs Mar 24, 20093SEC filing
May 4, 2009Amendment$3,164,325No comparisonNot reportedSEC filing
Mar 24, 2009Initial$200,000No comparisonNot reportedSEC filing
Jul 21, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jan 2, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Nov 1, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Nov 1, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Nov 1, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jul 14, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-62608
Amounts shown in Item 13 are for a second trache equity offering. Equity securities offered at the initial closing are shown on a Form D filed with the SEC on May 4, 2009.

Source: Form D, filed Oct 22, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Mark A. Braman Director, Executive
Robert Driver Executive
Joerg Neermann Director
Jorg Riesmeier Director
George Stagnitti Executive
Pascal Vinarnic Director
Peter Vitulli Director
Roger Wyse Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
7007 Winchester Circle Suite 120
Boulder, CO, 80301